Filing Details
- Accession Number:
- 0001415889-24-002065
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-01-31 16:23:31
- Reporting Period:
- 2024-01-29
- Accepted Time:
- 2024-01-31 16:23:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1382101 | Sutro Biopharma Inc. | STRO | Biological Products, (No Disgnostic Substances) (2836) | 452441988 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1877585 | Nicki Vasquez | C/O Sutro Biopharma, Inc. 111 Oyster Point Blvd. South San Francisco CA 94080 | Chief Port. Strat & Alnce Ofcr | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-01-29 | 12,185 | $5.00 | 12,803 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-01-29 | 2,500 | $0.00 | 15,303 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-01-29 | 1,024 | $4.99 | 14,279 | No | 4 | F | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Unit (RSU) | Disposition | 2024-01-29 | 2,500 | $0.00 | 2,500 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2024-01-29 | No | 4 | M | Direct |
Footnotes
- This transaction was entered into pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 29, 2023.
- Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person.
- Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement.
- The RSUs vest as to 1/4th of the total shares annually beginning on January 29, 2021, subject to the reporting person's provision of service to the issuer on each vesting date.
Billionaire Hedge Funds
